A Nutrition Education Module to Modify Sugar Consumptions Among Individuals With Cardio Metabolic Risks
- Conditions
- Cardiometabolic Syndrome
- Interventions
- Behavioral: Control Group (CG)Behavioral: Intervention Group (IG)
- Registration Number
- NCT05746000
- Lead Sponsor
- Universiti Putra Malaysia
- Brief Summary
The goal of this feasibility study is to assess the feasibility of a nutrition education module in modifying sugar consumption among individuals with cardiometabolic risk. The main questions it aims to answer are:
* Is the nutrition education (focusing on modifying sugars intake) intervention feasible to individuals with cardiometabolic risk?
* Can the intervention be delivered as planned and works as intended?
* What are the experiences, perspective and barriers of individuals with cardiometabolic risk when receiving the nutrition education intervention?
* Is the nutrition education intervention efficient in modifying the eating behaviour including the sugar consumption among individuals with cardiometabolic risk?
Participants in the Control Group and Intervention Group will attend three standard diet counselling, with additional sugar education for the Intervention Group.
- Detailed Description
This study aims to assess the feasibility of a nutrition education module in modifying sugar consumption among individuals with cardiometabolic risk. This feasibility study will recruit patients from the Teaching Hospital of Universiti Putra Malaysia. Subjects' selection will be based on the inclusion and exclusion criteria of the study. This is a three-month feasibility study. Participants will be randomly assigned into two groups (Control and Intervention Groups). Participants in the Control Group will attend three standard diet counselling at baseline, week-4, and week-8. Participants in the Intervention Group will also attend three individual diet counselling and will be educated about sugar calculation (sugar exchange).
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 60
-
Malaysian citizen
-
patients in Teaching Hospital of Universiti Putra Malaysia
-
aged 18-65 years old;
-
able to read, write and communicate either in Malay or English
-
education level of secondary school and above
-
able to use computer or gadgets (self-reported) with internet access at home
-
presence with cardiometabolic risk, defines as at least any three out of five risk factors based on:-
- waist circumference (men: ≥90cm, women: ≥80 cm) or;
- blood pressure (≥130/85 mmHg) or;
- having diabetes mellitus or fasting blood sugar (≥5.6mmol/L) or;
- triglyceride (≥1.7 mmol/L) or;
- high-density lipoprotein (men: <1.03 mmol/L, women: <1.3 mmol/L)
-
If on medication, on stabilised dose for at least 2 months before recruitment to the study
-
Daily free sugar intake ≥5% of the daily energy intake
- Diagnosed with mental illness (depression, bipolar disorder, schizophrenia, dementia)
- Uncontrolled type 2 diabetes defines as HbA1c of more than 8% or hypertriglyceridemia of >10 mmol/L
- Presence of chronic diseases-related complications such as liver disease or stage 3 chronic kidney disease
- Reported abnormal thyroid-stimulating hormones
- On cancer therapy
- Having lower limb disabilities
- Breastfeeding, pregnancy, or the desire to become pregnant in the next 3 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Group Control Group (CG) Participants in the control group will attend three standard diet counselling. Intervention Group Intervention Group (IG) Participants in the intervention group will attend three individual diet counselling and will be educated about sugar calculation (sugar exchange).
- Primary Outcome Measures
Name Time Method Proportion of subjects in the intervention group who take up the intervention At baseline of the intervention. All subjects who attend the intervention at baseline will be determined. This can be determined by dividing the subjects the intervention group who take up the intervention by the number of subjects who are randomly assigned to the intervention group.
Proportion of eligible potential candidates who agree to participate in the study At screening period. All subjects who agree to participate in the intervention will be determined. This can be determined by dividing the number of potential patients who agree to participate in the study by the total number of eligible patients in the patient lists.
Proportion of subjects who withdraw from the study or are lost to follow-up Three months of the intervention. All subjects who withdraw from the study or are lost to follow-up throughout the three months intervention will be determined. This can be determined by dividing the subjects who withdraw from the study or are lost to follow-up throughout the intervention by the total number of subjects who participate in the study at baseline.
- Secondary Outcome Measures
Name Time Method Dietary intake At baseline, week-4, week-8 and week-12 of the intervention. A 3-day Food Record will be used to determine the dietary intake.
Eating behaviour At baseline and week-12 of the intervention Eating behaviour will be determined using the Dutch Eating Behaviour Questionnaire (DEBQ), which will be evaluated based on a Likert scale with a scoring system identified as: 1 = never, 2 = seldom, 3 = sometimes, 4 = often, and 5 = very often.
Physical activity level At baseline and week-12 of the intervention Physical activity level will be measured using International Physical Activity Questionnaire (IPAQ). And the level will be categorised as low, moderate or high.
Knowledge level At baseline and week-12 of the intervention Knowledge level of healthy diet and sugar will be determined using the questions adapted from the Knowledge Assessment Questionnaire.
Fasting blood glucose At baseline and week-12 of the intervention Fasting blood glucose will be obtained from subjects' record in the Teaching Hospital of Universiti Putra Malaysia.
Waist circumference, hip circumference and waist-to-hip ratio At baseline and week-12 of the intervention Waist (centimeters) and hip circumference (centimeters) will be combined to report waist-to-hip ratio. Waist-to-hip ratio will be calculated using formula (waist circumference in cm/hip circumference in cm).
Insulin level At baseline and week-12 of the intervention Insulin level will be obtained from subjects' record in the Teaching Hospital of Universiti Putra Malaysia.
Dose received (what participants received) At week-12 of the intervention A self-reported evaluation survey and semi-structured interview will be conducted to measure the dose received. The participants will complete an evaluation survey immediately after the intervention to assess the usefulness and satisfaction of the intervention. A semi-structured interview will be conducted to determine the usefulness of intervention components, barriers to participation, and suggestions for improvements.
Weight, height and Body Mass Index (BMI) At baseline and week-12 of the intervention Weight (kilograms) and height (meters) will be combined to report BMI (kg/m2). BMI will be calculated using formula \[weight in kilograms/ (height in meters)2\] and cut-off point for normal BMI (18.5-24.9 kg/m2) will be used.
Health belief At baseline and week-12 of the intervention Health belief level will be determined using a Health Belief Model questionnaire, which will be evaluated based on a five Likert scale where the lowest score refers to strongly disagree, followed by disagree, neutral, agree and strongly agree.
Blood pressure At baseline and week-12 of the intervention Blood pressure will be obtained from subjects' record in the Teaching Hospital of Universiti Putra Malaysia.
Triglyceride At baseline and week-12 of the intervention Triglyceride level will be obtained from subjects' record in the Teaching Hospital of Universiti Putra Malaysia.
Reach (participation rate) At baseline, week-4, week-8 and week-12 of the intervention The participation rate will be determined by dividing the number of subjects who attend the session by the total number of subjects in the study.
Dietary sugar intake At baseline and week-12 of the intervention. A semi-quantitative Food Frequency Questionnaire of added sugar intake will be used to determine the dietary sugar intake.
LDL-cholesterol At baseline and week-12 of the intervention LDL-cholesterol level will be obtained from subjects' record in the Teaching Hospital of Universiti Putra Malaysia.
Fidelity (quality of the program delivered) At baseline, week-4, week-8 and week-12 of the intervention It will be measured based on observation and test account. For the diet counselling sessions, a score will be calculated to reflect the proportion of intended sessions that are delivered as scheduled. Also, a seven-item form will be used to assess whether the intended content of diet counselling is delivered. A test account will be used to monitor the message reminders received by the participants.
Trial Locations
- Locations (1)
Universiti Putra Malaysia
🇲🇾Serdang, Selangor, Malaysia